The module targets Claude Code, Claude Desktop, Cursor, Microsoft Visual Studio Code (VS Code) Continue, and Windsurf. It also harvests API keys for nine large language models (LLM) providers: ...

Leaked API keys are nothing new, but the scale of the problem in front-end code has been largely a mystery - until now. Intruder's research team built a new secrets detection method and scanned 5 ...

OpenAI has recently published a detailed architecture description of the Codex App Server, a bidirectional protocol that decouples the Codex coding agent's core logic from its various client surfaces.

Contains some strong language and adult humour. 10 February 2026 30 minutes Available for over a year SMASHBengali is joined by Shankeya, sitting in for Gura. They discuss the times when we have to ...

For many people, the day doesn’t begin without a hot cup of chai. But when this daily ritual occurs on an empty stomach, it can gradually affect digestion, acid levels, and even energy levels. While ...

Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques, like high-throughput screening, offer an ...

Chai Discovery’s AI platform, including purpose-built custom models, will be deployed to accelerate the discovery of next-generation therapeutics SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery, the AI ...

Chai Discovery, a biotech startup with backing from OpenAI, announced a $130 million Series B round at a $1.3 billion valuation on Monday. The round was led by General Catalyst and Oak HC/FT, the ...

Josh Meier, CEO of Chai Discovery, said his startup’s models are improving at a rapid rate. Courtesy Chai Discovery Chai Discovery, a San Francisco-based startup backed by OpenAI, is the latest drug ...

Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a “computer-aided design suite” for molecules. The deal, which values the company ...

Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to further energize development of its “computer-aided design suite” for new ...